CannabisNewsBreaks Archive - CannabisNewsWire

ThursdayApr 18, 2024 2:18 pm

CannabisNewsBreaks – Zoned Properties Inc. (ZDPY) Featured in Bell2Bell Podcast

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, was featured in the latest episode of the Bell2Bell Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Bryan McLaren, chairman and CEO of Zoned Properties, joined the program to provide an overview of the company’s business model and how his experience translates into the regulated cannabis space. “Zoned Properties, based in Scottsdale, Arizona, is focused on real estate and the regulated cannabis industry. Zoned Properties is essentially a technology-driven property investment company. We look at state-by-state markets…

ThursdayApr 18, 2024 1:56 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is announcing that Dr. David G. Morgan, PhD, a renowned leader in neurodegenerative disease, has joined its scientific advisory board (“SAB”). The announcement noted that the addition reinforces the company’s commitment to advancing its INM-901 program in the treatment of Alzheimer’s disease. Dr. Morgan is the Director of the Alzheimer’s Alliance and MSU Foundation Professor of Translational Neuroscience at Michigan State University. His research interests are Alzheimer’s disease, aging and brain function. “We are privileged to welcome someone of Dr. Morgan’s…

WednesdayApr 17, 2024 3:39 pm

CannabisNewsBreaks – BizCann Expo Colombia to Showcase Insights on Emerging Trends in Canna-Business Landscape

The BizCann Expo, produced and hosted by ZJ Events, today announced the next rendition of its premier cannabis confab. Set to take place at the sleek Plaza Mayor in Medellin, Colombia, from May 18-19, the expo follows a series of blowout events in both North and South America. BizCann Expo is among the world’s elite business and networking events, leading industry innovation, entrepreneurship and education across all aspects of the cannabis industry. BizCann Expo provides novices as well as established players in the canna-business arena the ideal platform to elevate ventures and services in this burgeoning sector. This year’s event…

TuesdayApr 16, 2024 3:47 pm

CannabisNewsBreaks – Vape South America Medellín 2024 to Showcase Innovation in Alternative Products Supply Chain

Alternative Products Expo has announced the return of the world’s premier counterculture industry event to Medellín, Colombia. Another first-class production of ZJ Events, Vape South America Medellín 2024 is slated to take place at the Centro de Convenciones Plaza Mayor in Medellín from May 18-19, 2024. Strategically located with a welcoming atmosphere and great climate, the Vape South America Medellín 2024 has become a prime gateway between the U.S. and South American markets and offers a unique opportunity to establish connections with buyers and distributors from around the globe. “Vape South America Medellín 2024 is a globally renowned platform in…

TuesdayApr 16, 2024 3:42 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Approval to Commence Human Pilot Study Evaluating GLP-1, DehydraTECH

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot study. The approval, which was granted by an independent third-party ethics review board, enables Lexaria to move forward with its plan to conduct a GLP-1 study investigating GLP-1 drugs and DehydraTECH(TM). According to the announcement, subject recruitment will begin immediately with the first dosing expected within the next month; the company plans to complete the study this summer. The study will be comprised of two study arms and will include up to nine healthy volunteers. The study is designed to…

TuesdayApr 16, 2024 1:31 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate positive pharmacological effects in the treatment of dry age-related macular degeneration (“AMD”). According to the announcement, in vivo preclinical studies in AMD disease models show that INM-089 delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement. Earlier results showed that INM-089 also preserved retinal function…

FridayApr 12, 2024 3:26 pm

CannabisNewsBreaks – Zoned Properties Inc. (ZDPY) Continues to Align with Evolving Cannabis Market

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focusing on seizing direct-to-consumer real estate opportunities in the rapidly growing and regulated cannabis market. This is amid changing regulations and attitudes towards cannabis use, which are transforming the industry. “Cannabis businesses are expanding significantly as regulations evolve, leading to an increased demand for specialized, direct-to-consumer properties that include dispensaries, manufacturing or processing centers, and distribution hubs. Real estate investors are capitalizing on this demand by acquiring properties for rental income generation while potentially realizing significant property value appreciation as the industry grows,” a…

ThursdayApr 11, 2024 11:06 am

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Announce Acquisition, Strengthen Position as ‘Powerhouse’ in Entertainment Space

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, and its wholly owned subsidiary, Lavish Entertainment, have closed on the full acquisition of ABI Create, a premier event-management and production company. ABI Create was founded in 2015 by Lavish Entertainment president and COO Marco Antonio Moreno. Since its inception, ABI Create has established a reputation for delivering high-quality productions for a range of large-scale installations at major music festivals, sporting events and conventions. The company has partnered with the NFL Super Bowl, San Diego and New York Comic Con events, EDC and Camp EDC, Bonnaroo Music Festival, the Waste Management…

WednesdayApr 10, 2024 3:40 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Moving Toward Vision to Become World-Leading Integrated Cannabis Company

Software Effective Solutions (OTC: SFWJ), a leading holding company in the cannabis industry, is growing its footprint through savvy acquisitions. “[In February], the company announced that it was in the final stages of negotiations to acquire its sixth cannabis company in Colombia. This strategic acquisition is extremely significant because the targeted company holds a unique cannabis genetics license, which MedCana believes will revolutionize its potential to create and register unique cannabis genetic varieties for production and commercialization… Early in March, MedCana completed the previously announced acquisition plus the acquisition of a second company, bringing the number of companies in MedCana’s…

ThursdayApr 04, 2024 2:23 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studies

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting additional preclinical data demonstrating the positive effects of its INM-901 for the potential treatment of Alzheimer's disease ("AD"). Highlights of the report note that INM-901 receptor binding studies indicate preferential signaling agonism for both cannabinoid 1 (“CB1”) and cannabinoid 2 (“CB2”) and impacts the peroxisome proliferator-activated receptors (“PPAR”) signaling pathway while in vivo studies demonstrate INM-901 reduces neuroinflammation and improves neuronal function. In addition, molecular analysis data explains previously reported observations in behavioral studies on locomotion, memory and cognition. According…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks